VFLO stock forecast, quote, news & analysis

Key Takeaways

• VFLO climbed roughly 12% over the last 30 days, from about $49.7 to $55.6 per share.
• The fund extended a steady multi-month uptrend, gaining approximately 19% over the trailing quarter.
• VFLO is a rules-based, passively managed fund tracking the Victory U.S. Large Cap Free Cash Flow Index, with about 51 holdings and a 0.39% net expense ratio.
• Heavy weightings in technology, energy, and healthcare have shaped the fund's recent and longer-term performance.
• Free cash flow (FCF) quality and a value tilt remain the fund's core investment themes.

VictoryShares Free Cash Flow ETF (VFLO) Overview and Portfolio Exposure

The VictoryShares Free Cash Flow ETF (VFLO) seeks to track, before fees and expenses, the performance of the Victory U.S. Large Cap Free Cash Flow Index. The index uses a rules-based methodology that selects 50 companies from the S-Network U.S. Equity Large/Mid-Cap 1000 universe, screening for strong free cash flow yield, which measures operating cash flow minus capital expenditures relative to market value, combined with favorable growth metrics. VFLO launched in June 2023 and has grown to roughly $10 billion in assets under management (AUM).

The portfolio holds about 51 stocks, with notable positions in ADBE, EXPE, ACN, DVN, INTU, CRM, THC, XOM, BKNG, and MRK. By sector, information technology accounts for roughly 32% of assets, energy about 23%, healthcare about 20%, and consumer cyclical approximately 10%, with smaller allocations to materials and communication services. This concentration in cash-generative technology, energy, and healthcare names distinguishes VFLO from broad large-cap value benchmarks and helps explain its recent behavior.

VictoryShares Free Cash Flow ETF (VFLO) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, VFLO advanced from roughly $49.7 to about $55.6, a gain of approximately 12%. The move was trend-driven rather than volatile, characterized by a sequence of higher daily closes and limited drawdowns, particularly during the second half of the period.

The quarterly picture is even stronger. From roughly $46.6 at the end of May to the latest close near $55.6, the fund gained about 19%. This represents a continuation of an established uptrend rather than a sudden spike, with the fund grinding steadily higher across the three-month window while broad equity indexes also firmed.

What Drove VFLO Price in the Last 30 Days

VFLO's recent advance reflected broad participation across its largest sector exposures rather than a single catalyst. The fund's overweight to energy—roughly 23% of assets versus a low-single-digit weighting in many broad benchmarks—positioned it to benefit from firming energy-market conditions, with holdings such as Devon Energy and ExxonMobil contributing to the move.

Technology, the fund's largest allocation at about 32%, also provided support, with positions including Adobe, Salesforce, Intuit, and Accenture among the portfolio's top contributors by weight. Healthcare exposure, led by names such as Merck and Tenet Healthcare, added further ballast. The fund's materials sleeve, which includes gold miners like Newmont and Coeur Mining, also benefited as precious-metals-related equities firmed. Because VFLO emphasizes companies with robust free cash flow generation and reasonable valuations, the portfolio was well positioned to capture a risk-on advance while retaining a quality-oriented, value tilt.

What Drove VFLO Performance Over the Last Quarter

Over the trailing three months, VFLO's gains reflected a longer-running rotation toward profitable, cash-generative businesses. Investors continued to reward companies that can self-fund operations and return capital, a theme central to the fund's free-cash-flow methodology. The fund's structural overweights in energy and healthcare, relative to the broader large-cap market, supported returns as those segments attracted steady demand.

Unlike the narrow leadership sometimes seen in momentum-driven indexes, VFLO's quarterly performance was relatively diversified, with technology, energy, and healthcare all contributing. The fund's rules-based approach—which ranks the top free-cash-flow-yield companies and tilts toward those with higher expected growth—kept the portfolio aligned with this broader "quality at a discount" narrative. Institutional flows into cash-flow-focused strategies have also reinforced demand for this style of exposure.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. Rather than manually reviewing chart after chart, users can apply customizable criteria to surface ideas aligned with their own approach, whether they are focused on breakout candidates, momentum, valuation, or sector rotation. The screener is designed to make the research process more efficient and objective, complementing traditional ETF analysis with quantitative, rule-based screening. Investors looking to monitor themes such as free cash flow, energy exposure, or technology leadership can use the AI Screener to track relevant opportunities alongside holdings like those in VFLO.

VFLO ETF Outlook: What Investors Should Watch Next

Several factors are likely to influence VFLO over the coming months. Energy remains a key swing factor given the fund's roughly 23% weighting; investors should monitor commodity price trends, supply-demand balances, and capital discipline among major producers. The technology allocation's performance will hinge on enterprise software demand and the earnings trajectory of names such as Adobe, Salesforce, and Intuit.

The macroeconomic environment matters broadly for a cash-flow-focused fund. Interest rate expectations and inflation trends can shift the relative appeal of value-oriented, cash-generative companies, while economic growth data influences demand across energy and healthcare. Healthcare policy and drug-pricing developments remain relevant to the fund's sizable healthcare sleeve, and precious-metals prices will continue to shape the materials allocation. Finally, capital flows into free-cash-flow and quality-value strategies could affect demand for VFLO specifically. None of these themes constitutes a prediction; rather, they represent the structural drivers investors may watch when evaluating this ETF's risk and opportunity set.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations